Tamoxifen
SOLTAMOX is an estrogen agonist/antagonist indicated: For treatment of adult patients with estrogen receptor-positive metastatic breast cancer ( 1.1 ) For adjuvant treatment of adult patients with early stage estrogen receptor- positive breast cancer ( 1.2 ) To reduce risk of invasive breast cancer…
United States
$12
per month
India
$0
per month
You save
−97%save $11/mo · 97% cheaper
383.7K US scripts/yr$4.4M potential annual savings$4.5M US spend/yr
Drag to rotate · 3D structureC26H29NO
SMILES: CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3
Compare the price
US price$12per month
India price$0per month
You save$1196% less
Based on 30 units per month. US $0.39 vs India $0.02 per unit.
Total over 1 periodSave $11$12 → $0
The bigger picture
Tamoxifen is filled about 383.7K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$4.5M
If sourced from India
$126.6K
Potential annual savings
$4.4M
−97%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.